SEVELAMER CARBONATE

SEVELAMER CARBONATE was reported 11506 times

SEVELAMER CARBONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARATHYROID SCAN ABNORMAL 6 0.7500
1 CRYSTAL DEPOSIT INTESTINE 49 0.2279
2 PERITONEAL DIALYSATE LEAKAGE 6 0.1818
3 VENTRICULAR HYPERKINESIA 13 0.1461
4 THERAPEUTIC AGENT-DIAGNOSTIC TEST INTERACTION 6 0.1304
5 DIALYSIS HYPOTENSION 9 0.0909
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 86 0.0810
7 HYPERPHOSPHATAEMIA 169 0.0785
8 VASCULAR ACCESS MALFUNCTION 4 0.0741
9 HYPERPARATHYROIDISM SECONDARY 182 0.0726
10 SECONDARY HYPERTHYROIDISM 7 0.0722
11 RIGHT ATRIAL ENLARGEMENT 13 0.0657
12 HYPOCHROMASIA 13 0.0647
13 NEPHROGENIC ANAEMIA 298 0.0643
14 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 11 0.0588
15 ARTERIOVENOUS FISTULA SITE INFECTION 7 0.0519
16 ARTERIOVENOUS FISTULA OCCLUSION 9 0.0514
17 LEFT VENTRICULAR ENLARGEMENT 13 0.0510
18 MITRAL VALVE THICKENING 13 0.0436
19 AORTO-OESOPHAGEAL FISTULA 4 0.0417
20 ISCHAEMIC ENTERITIS 4 0.0412
21 BLOOD PHOSPHORUS ABNORMAL 18 0.0382
22 END STAGE RENAL DISEASE 674 0.0369
23 DIALYSIS DEVICE INSERTION 4 0.0367
24 DIALYSIS RELATED COMPLICATION 11 0.0311
25 ARTERIOVENOUS FISTULA OPERATION 8 0.0296
26 HAEMODIALYSIS COMPLICATION 5 0.0294
27 ARTERIOVENOUS FISTULA THROMBOSIS 10 0.0289
28 BLOOD PHOSPHORUS INCREASED 78 0.0285
29 PLEUROPERITONEAL COMMUNICATION 4 0.0280
30 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 7 0.0279
31 INADEQUATE PERITONEAL DIALYSIS 4 0.0261
32 LEFT ATRIAL ENLARGEMENT 14 0.0260
33 TRANSFERRIN SATURATION INCREASED 8 0.0233
34 REBOUND ACID HYPERSECRETION 70 0.0231
35 ASYMPTOMATIC BACTERIURIA 3 0.0221
36 MEAN PLATELET VOLUME INCREASED 13 0.0215
37 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 4 0.0202
38 RENAL HYPERTENSION 6 0.0193
39 BLOOD PARATHYROID HORMONE ABNORMAL 12 0.0190
40 PERIRENAL HAEMATOMA 4 0.0184
41 GASTROINTESTINAL MUCOSAL DISORDER 12 0.0183
42 TRANSFERRIN SATURATION DECREASED 7 0.0164
43 SERUM FERRITIN ABNORMAL 5 0.0156
44 COMMINUTED FRACTURE 5 0.0150
45 PARATHYROIDECTOMY 7 0.0146
46 SKIN FIBROSIS 7 0.0145
47 RECTAL ULCER 15 0.0128
48 ILEAL PERFORATION 8 0.0121
49 ORAL ADMINISTRATION COMPLICATION 11 0.0118
50 CONSTIPATION 2548 0.0117
51 ARTERIOVENOUS FISTULA SITE COMPLICATION 7 0.0117
52 LARGE INTESTINAL ULCER HAEMORRHAGE 4 0.0115
53 LARGE INTESTINAL ULCER 30 0.0110
54 FEEDING TUBE USER 4 0.0109
55 MUCOSAL ULCERATION 11 0.0109
56 SPONTANEOUS HAEMATOMA 8 0.0107
57 CALCIPHYLAXIS 19 0.0103
58 RENAL TRANSPLANT 37 0.0102
59 BLOOD PARATHYROID HORMONE INCREASED 29 0.0099
60 DELAYED GRAFT FUNCTION 7 0.0098
61 SHUNT OCCLUSION 5 0.0098
62 PERITONEAL DIALYSIS 8 0.0097
63 JOB DISSATISFACTION 6 0.0092
64 HYPERTENSIVE HEART DISEASE 17 0.0091
65 BLOOD CALCIUM ABNORMAL 15 0.0090
66 DIALYSIS 128 0.0090
67 HYPERVOLAEMIA 44 0.0089
68 CHRONIC KIDNEY DISEASE 676 0.0089
69 BACTERIURIA 5 0.0088
70 PRECOCIOUS PUBERTY 5 0.0088
71 PROCEDURAL HYPOTENSION 7 0.0082
72 PERITONITIS BACTERIAL 82 0.0081
73 NEPHROGENIC SYSTEMIC FIBROSIS 24 0.0079
74 DRY GANGRENE 5 0.0079
75 EXTREMITY CONTRACTURE 5 0.0078
76 SPONTANEOUS HAEMORRHAGE 8 0.0078
77 AMYOTROPHY 3 0.0078
78 BLOOD CHLORIDE INCREASED 13 0.0075
79 AMMONIA ABNORMAL 3 0.0074
80 SKIN INDURATION 15 0.0072
81 ABDOMINAL CAVITY DRAINAGE 3 0.0071
82 FOREIGN BODY ASPIRATION 5 0.0069
83 AZOTAEMIA 27 0.0068
84 PLASMA CELL LEUKAEMIA 4 0.0067
85 SERUM FERRITIN INCREASED 35 0.0066
86 PRODUCT COMMINGLING 7 0.0066
87 JOINT CONTRACTURE 7 0.0065
88 PERITONEAL HAEMORRHAGE 9 0.0065
89 STREPTOCOCCAL BACTERAEMIA 7 0.0064
90 LABORATORY TEST INTERFERENCE 5 0.0064
91 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10 0.0062
92 ANGIOPLASTY 9 0.0060
93 CONGENITAL CYSTIC KIDNEY DISEASE 5 0.0059
94 ELECTROCARDIOGRAM T WAVE INVERSION 13 0.0059
95 PERITONEAL CLOUDY EFFLUENT 8 0.0058
96 HYPERPARATHYROIDISM 12 0.0058
97 METABOLIC ENCEPHALOPATHY 17 0.0057
98 RENAL INJURY 167 0.0056
99 GASTROINTESTINAL INJURY 15 0.0056
100 ANAEMIA OF CHRONIC DISEASE 5 0.0055
101 PARATHYROID TUMOUR BENIGN 4 0.0054
102 APLASIA PURE RED CELL 18 0.0052
103 ACUTE LUNG INJURY 6 0.0051
104 RENAL FAILURE 666 0.0050
105 SKIN HYPERTROPHY 14 0.0050
106 HAPTOGLOBIN DECREASED 4 0.0050
107 FLUID OVERLOAD 72 0.0049
108 ILEAL ULCER 5 0.0049
109 GASTROINTESTINAL HYPOMOTILITY 11 0.0049
110 DIASTOLIC DYSFUNCTION 15 0.0049
111 PERITONITIS 100 0.0048
112 SCIATIC NERVE INJURY 4 0.0048
113 GASTROINTESTINAL NECROSIS 14 0.0048
114 NEPHROPATHY 43 0.0046
115 CATHETER SITE INFECTION 17 0.0045
116 GASTROINTESTINAL MOTILITY DISORDER 24 0.0045
117 FLATULENCE 251 0.0044
118 OPTIC NERVE INJURY 5 0.0043
119 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
120 RENAL TRANSPLANT FAILURE 4 0.0040
121 ULTRAFILTRATION FAILURE 8 0.0040
122 FUNGAL PERITONITIS 6 0.0039
123 BLOOD POTASSIUM INCREASED 64 0.0039
124 FEAR OF DISEASE 7 0.0039
125 BLOODY PERITONEAL EFFLUENT 4 0.0039
126 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 13 0.0039
127 HEPATIC INFECTION 5 0.0039
128 HIGH DENSITY LIPOPROTEIN DECREASED 13 0.0039
129 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
130 ORCHITIS 4 0.0037
131 LEG AMPUTATION 15 0.0036
132 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
133 CATHETER SITE HAEMORRHAGE 9 0.0036
134 CALCINOSIS 8 0.0036
135 COLITIS ISCHAEMIC 24 0.0036
136 BLOOD PHOSPHORUS DECREASED 13 0.0036
137 AORTIC VALVE INCOMPETENCE 15 0.0035
138 MOANING 4 0.0035
139 BLOOD PRESSURE SYSTOLIC DECREASED 16 0.0035
140 BLOOD URIC ACID INCREASED 20 0.0035
141 ARTERIAL STENOSIS 3 0.0034
142 NODAL RHYTHM 5 0.0034
143 ANOGENITAL WARTS 3 0.0034
144 ACUTE KIDNEY INJURY 515 0.0034
145 ESSENTIAL HYPERTENSION 6 0.0033
146 HAEMATOCRIT ABNORMAL 4 0.0033
147 DIFFUSE ALOPECIA 6 0.0032
148 INTRA-ABDOMINAL HAEMATOMA 4 0.0032
149 ACUTE PULMONARY OEDEMA 18 0.0032
150 DIABETIC NEPHROPATHY 7 0.0032
151 ECONOMIC PROBLEM 48 0.0032
152 HAEMODIALYSIS 26 0.0031
153 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
154 FAECES HARD 12 0.0031
155 PULMONARY ARTERIAL PRESSURE INCREASED 5 0.0031
156 ANAEMIA POSTOPERATIVE 4 0.0031
157 CONTRAINDICATED PRODUCT PRESCRIBED 5 0.0030
158 ANHEDONIA 78 0.0030
159 RENAL TUBULAR NECROSIS 29 0.0030
160 TOE AMPUTATION 15 0.0030
161 EROSIVE OESOPHAGITIS 5 0.0029
162 MENISCUS LESION 4 0.0029
163 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
164 RENAL FAILURE CHRONIC 22 0.0029
165 PRODUCT MONITORING ERROR 4 0.0028
166 KIDNEY TRANSPLANT REJECTION 13 0.0027
167 HYPERKALAEMIA 95 0.0027
168 BLOOD PARATHYROID HORMONE DECREASED 4 0.0027
169 LARGE INTESTINAL OBSTRUCTION 6 0.0027
170 HYPOCALCAEMIA 50 0.0026
171 PRURITUS 1009 0.0026
172 BLOOD CALCIUM INCREASED 23 0.0026
173 CERVICAL VERTEBRAL FRACTURE 9 0.0026
174 AORTIC STENOSIS 9 0.0026
175 SKIN TIGHTNESS 12 0.0025
176 FUNGAEMIA 4 0.0025
177 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
178 ENDOCARDITIS 13 0.0025
179 STAPHYLOCOCCAL BACTERAEMIA 11 0.0025
180 GANGRENE 15 0.0025
181 DEVICE RELATED SEPSIS 5 0.0025
182 DIVERTICULAR PERFORATION 5 0.0024
183 AMPUTATION 3 0.0024
184 BLOOD CALCIUM DECREASED 27 0.0024
185 AORTIC VALVE REPLACEMENT 3 0.0024
186 AMYLOIDOSIS 4 0.0023
187 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
188 MITRAL VALVE INCOMPETENCE 25 0.0022
189 BLOOD LOSS ANAEMIA 5 0.0022
190 PNEUMOPERITONEUM 4 0.0022
191 CATHETER PLACEMENT 4 0.0022
192 GASTRITIS EROSIVE 10 0.0021
193 PERIPHERAL VASCULAR DISORDER 11 0.0021
194 HYPERCALCAEMIA 26 0.0021
195 ANXIETY DISORDER 7 0.0021
196 PANCREATIC CYST 4 0.0021
197 PARAPLEGIA 6 0.0021
198 ABDOMINAL WALL HAEMATOMA 4 0.0020
199 INTESTINAL OBSTRUCTION 77 0.0020
200 ACUTE PSYCHOSIS 5 0.0020
201 DEVICE INFUSION ISSUE 5 0.0020
202 TRICUSPID VALVE INCOMPETENCE 16 0.0020
203 BLOOD CULTURE POSITIVE 6 0.0020
204 GASTROINTESTINAL TUBE INSERTION 5 0.0020
205 NORMOCHROMIC NORMOCYTIC ANAEMIA 6 0.0020
206 VASODILATATION 5 0.0020
207 FOAMING AT MOUTH 4 0.0020
208 PRODUCT CONTAMINATION 7 0.0020
209 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 8 0.0020
210 FIBROSIS 6 0.0019
211 BLOOD CHLORIDE DECREASED 5 0.0019
212 FAECES DISCOLOURED 42 0.0019
213 LUNG INFILTRATION 17 0.0019
214 LARGE INTESTINE PERFORATION 13 0.0019
215 QUALITY OF LIFE DECREASED 25 0.0019
216 ENTEROCOCCAL INFECTION 9 0.0019
217 AORTIC VALVE DISEASE 3 0.0019
218 DYSPEPSIA 181 0.0018
219 RENAL TUBULAR ACIDOSIS 4 0.0018
220 UNRESPONSIVE TO STIMULI 47 0.0018
221 ACUTE RESPIRATORY FAILURE 35 0.0018
222 RETROPERITONEAL HAEMATOMA 4 0.0018
223 MUSCLE RUPTURE 7 0.0018
224 TONGUE BLISTERING 4 0.0018
225 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
226 TRANSPLANT REJECTION 14 0.0017
227 DERMATITIS EXFOLIATIVE GENERALISED 6 0.0017
228 SHOCK HAEMORRHAGIC 14 0.0017
229 HAEMATOCRIT DECREASED 34 0.0017
230 PERIPHERAL ISCHAEMIA 7 0.0017
231 UMBILICAL HERNIA 8 0.0017
232 ACIDOSIS 13 0.0017
233 PURPURA 15 0.0017
234 MENTAL STATUS CHANGES 47 0.0017
235 TRANSPLANT 4 0.0017
236 URINE ANALYSIS ABNORMAL 5 0.0017
237 TREATMENT NONCOMPLIANCE 91 0.0017
238 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
239 PERITONEAL DIALYSIS COMPLICATION 12 0.0016
240 DIARRHOEA 1057 0.0016
241 DUODENITIS 5 0.0016
242 DERMAL CYST 4 0.0016
243 RETROPERITONEAL HAEMORRHAGE 4 0.0016
244 STAPHYLOCOCCAL SEPSIS 8 0.0016
245 INFLAMMATORY MARKER INCREASED 8 0.0016
246 BLOOD UREA INCREASED 27 0.0016
247 RENAL DISORDER 75 0.0016
248 BACTERAEMIA 19 0.0016
249 STATUS EPILEPTICUS 18 0.0016
250 PULMONARY HYPERTENSION 33 0.0016
251 ABDOMINAL ABSCESS 7 0.0016
252 GASTROENTERITIS 23 0.0016
253 HAEMODYNAMIC INSTABILITY 12 0.0016
254 INCREASED BRONCHIAL SECRETION 4 0.0016
255 OESOPHAGEAL ULCER 6 0.0016
256 EOSINOPHIL COUNT INCREASED 13 0.0016
257 AORTIC ARTERIOSCLEROSIS 4 0.0016
258 REHABILITATION THERAPY 6 0.0015
259 FAILURE TO THRIVE 8 0.0015
260 TRANSFUSION 16 0.0015
261 THROMBOSIS IN DEVICE 5 0.0015
262 BLOOD LACTIC ACID INCREASED 8 0.0015
263 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
264 BLOOD POTASSIUM ABNORMAL 4 0.0015
265 FOREIGN BODY 6 0.0015
266 EOSINOPHILIA 26 0.0015
267 INGUINAL HERNIA 9 0.0015
268 DECUBITUS ULCER 12 0.0015
269 WOUND COMPLICATION 5 0.0015
270 INTESTINAL ISCHAEMIA 8 0.0015
271 HAEMOGLOBIN DECREASED 149 0.0014
272 COLITIS 55 0.0014
273 METABOLIC ACIDOSIS 46 0.0014
274 OSTEOMYELITIS 26 0.0014
275 CARDIAC ARREST 118 0.0014
276 ENDOTRACHEAL INTUBATION 4 0.0014
277 RIGHT VENTRICULAR FAILURE 10 0.0014
278 DUODENAL ULCER HAEMORRHAGE 4 0.0014
279 APPENDICITIS 13 0.0014
280 TOXIC ENCEPHALOPATHY 7 0.0014
281 POST PROCEDURAL HAEMORRHAGE 16 0.0014
282 DEVICE POWER SOURCE ISSUE 4 0.0014
283 PULMONARY PAIN 4 0.0014
284 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
285 INTESTINAL PERFORATION 15 0.0013
286 ABDOMINAL PAIN 308 0.0013
287 HAEMOGLOBIN INCREASED 6 0.0013
288 PLASMA CELL MYELOMA 51 0.0013
289 DIABETIC FOOT 4 0.0013
290 DECREASED ACTIVITY 14 0.0013
291 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
292 HOSPITALISATION 199 0.0013
293 FULL BLOOD COUNT DECREASED 26 0.0013
294 FAECALOMA 7 0.0013
295 CHOKING SENSATION 7 0.0013
296 BLOOD IRON DECREASED 15 0.0013
297 ATRIAL FLUTTER 10 0.0013
298 ENTERITIS 8 0.0012
299 SEPTIC SHOCK 54 0.0012
300 SEPSIS 138 0.0012
301 INFUSION SITE HAEMORRHAGE 4 0.0012
302 NEPHRITIS 4 0.0012
303 HYPOVOLAEMIA 7 0.0012
304 UROSEPSIS 11 0.0012
305 PRODUCT SOLUBILITY ABNORMAL 6 0.0012
306 KLEBSIELLA INFECTION 6 0.0012
307 WOUND DEHISCENCE 4 0.0012
308 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
309 ABDOMINAL INFECTION 3 0.0012
310 SUDDEN CARDIAC DEATH 4 0.0012
311 ECCHYMOSIS 8 0.0012
312 TYPE 1 DIABETES MELLITUS 7 0.0012
313 ANURIA 10 0.0012
314 HEPATIC LESION 5 0.0012
315 PELVIC FRACTURE 9 0.0012
316 ATELECTASIS 11 0.0011
317 TUMOUR LYSIS SYNDROME 10 0.0011
318 VOMITING 533 0.0011
319 GOUT 20 0.0011
320 PRODUCT TASTE ABNORMAL 15 0.0011
321 BLOOD CREATININE INCREASED 72 0.0011
322 DISEASE COMPLICATION 5 0.0011
323 FOOD INTOLERANCE 4 0.0011
324 MOUTH HAEMORRHAGE 8 0.0011
325 RESPIRATORY FAILURE 79 0.0011
326 INCOHERENT 7 0.0011
327 LYMPHOCYTE COUNT DECREASED 19 0.0011
328 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
329 PULMONARY OEDEMA 48 0.0011
330 RENAL IMPAIRMENT 90 0.0011
331 DIARRHOEA HAEMORRHAGIC 10 0.0011
332 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
333 APPETITE DISORDER 7 0.0011
334 TROPONIN INCREASED 8 0.0011
335 PULSE ABSENT 5 0.0011
336 RED BLOOD CELL COUNT DECREASED 30 0.0010
337 MEDICATION RESIDUE PRESENT 5 0.0010
338 CARDIAC OPERATION 9 0.0010
339 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
340 GASTRIC INFECTION 4 0.0010
341 SKIN ULCER 27 0.0010
342 HYPOTENSION 209 0.0010
343 DEVICE RELATED INFECTION 16 0.0010
344 NAUSEA 819 0.0010
345 HAEMATOCHEZIA 57 0.0010
346 GASTROINTESTINAL HAEMORRHAGE 86 0.0010
347 DECREASED INTEREST 6 0.0010
348 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
349 BLOOD ALBUMIN DECREASED 8 0.0010
350 RENAL CYST 8 0.0010
351 ASPIRATION 11 0.0010
352 DIVERTICULUM 7 0.0010
353 ABNORMAL FAECES 8 0.0010
354 CARDIOMEGALY 12 0.0010
355 CHOKING 19 0.0010
356 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
357 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 68 0.0010
358 MELAENA 21 0.0010
359 ASCITES 28 0.0010
360 PRODUCT USE COMPLAINT 15 0.0010
361 SKIN PLAQUE 8 0.0009
362 HYPOPHOSPHATAEMIA 7 0.0009
363 LEUKOCYTOSIS 17 0.0009
364 POOR PERIPHERAL CIRCULATION 4 0.0009
365 ABSCESS LIMB 4 0.0009
366 RETCHING 20 0.0009
367 DYSPHAGIA 89 0.0009
368 PRODUCT SIZE ISSUE 5 0.0009
369 BLOOD MAGNESIUM DECREASED 8 0.0009
370 PRURITUS GENERALISED 20 0.0009
371 THROMBOTIC MICROANGIOPATHY 9 0.0009
372 VITAMIN D DEFICIENCY 9 0.0009
373 OCULAR ICTERUS 4 0.0009
374 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
375 ANAEMIA 176 0.0009
376 OESOPHAGITIS 10 0.0009
377 URINE OUTPUT DECREASED 8 0.0009
378 DIVERTICULUM INTESTINAL 4 0.0009
379 BOWEL MOVEMENT IRREGULARITY 7 0.0009
380 HOSPICE CARE 9 0.0009
381 HAEMORRHAGIC ANAEMIA 4 0.0009
382 GASTRIC ULCER HAEMORRHAGE 5 0.0009
383 CARDIAC FAILURE ACUTE 6 0.0009
384 HYPERTENSIVE CRISIS 10 0.0009
385 ENCEPHALOPATHY 22 0.0009
386 SMALL INTESTINAL OBSTRUCTION 11 0.0009
387 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
388 FISTULA 10 0.0009
389 POSTOPERATIVE WOUND INFECTION 6 0.0009
390 BONE MARROW FAILURE 18 0.0009
391 POST PROCEDURAL COMPLICATION 17 0.0009
392 VASCULAR DEVICE INFECTION 4 0.0009
393 DRUG ADMINISTRATION ERROR 27 0.0009
394 CARDIOMYOPATHY 13 0.0009
395 CARDIAC VALVE DISEASE 5 0.0009
396 CARDIAC FAILURE 70 0.0009
397 JOINT EFFUSION 6 0.0009
398 RENAL FUNCTION TEST ABNORMAL 4 0.0009
399 RECTAL HAEMORRHAGE 37 0.0009
400 ABDOMINAL DISCOMFORT 144 0.0009
401 MULTIPLE MYELOMA 4 0.0009
402 HEPATIC ENCEPHALOPATHY 8 0.0009
403 NEUROTOXICITY 15 0.0009
404 TIBIA FRACTURE 4 0.0009
405 ACUTE MYOCARDIAL INFARCTION 25 0.0008
406 MYOCLONUS 10 0.0008
407 HYPERLIPIDAEMIA 10 0.0008
408 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
409 OEDEMA 45 0.0008
410 HERNIA 16 0.0008
411 LOCALISED INFECTION 20 0.0008
412 FLUID RETENTION 42 0.0008
413 PSEUDOMONAS INFECTION 7 0.0008
414 BLOOD PRESSURE DECREASED 54 0.0008
415 VENTRICULAR FIBRILLATION 9 0.0008
416 CARDIAC MURMUR 7 0.0008
417 IMPAIRED GASTRIC EMPTYING 11 0.0008
418 OLIGURIA 5 0.0008
419 HYPOGLYCAEMIA 39 0.0008
420 GASTROINTESTINAL DISORDER 72 0.0008
421 PROTEIN URINE PRESENT 4 0.0008
422 HYDRONEPHROSIS 6 0.0008
423 DYSPNOEA EXERTIONAL 30 0.0008
424 CORONARY ARTERY DISEASE 24 0.0008
425 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
426 PLEURAL EFFUSION 48 0.0008
427 AMMONIA INCREASED 4 0.0008
428 LIPASE INCREASED 6 0.0008
429 LABORATORY TEST ABNORMAL 23 0.0008
430 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
431 CACHEXIA 4 0.0008
432 HAEMOGLOBIN ABNORMAL 5 0.0008
433 INFUSION SITE PAIN 10 0.0008
434 SKIN NECROSIS 4 0.0008
435 ANGINA UNSTABLE 5 0.0008
436 HAEMORRHAGIC STROKE 6 0.0008
437 CARDIOGENIC SHOCK 11 0.0008
438 MALABSORPTION 4 0.0008
439 DIVERTICULITIS 21 0.0008
440 CELLULITIS 38 0.0008
441 PNEUMONIA 243 0.0007
442 BACTERIAL INFECTION 14 0.0007
443 DEFORMITY 7 0.0007
444 CARDIO-RESPIRATORY ARREST 31 0.0007
445 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
446 PROTEINURIA 14 0.0007
447 PERICARDIAL EFFUSION 17 0.0007
448 CYTOPENIA 9 0.0007
449 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
450 CARDIAC FAILURE CONGESTIVE 59 0.0007
451 WOUND INFECTION 8 0.0007
452 ANAPHYLACTOID REACTION 3 0.0007
453 DEATH 628 0.0007
454 LARGE INTESTINE POLYP 5 0.0007
455 DRUG DOSE OMISSION 119 0.0007
456 RASH MACULO-PAPULAR 16 0.0007
457 NECROSIS 4 0.0007
458 HAEMORRHOIDS 14 0.0007
459 MALNUTRITION 8 0.0007
460 C-REACTIVE PROTEIN INCREASED 26 0.0007
461 ANGIOPATHY 4 0.0007
462 EMOTIONAL DISTRESS 86 0.0007
463 HEPATOCELLULAR INJURY 10 0.0007
464 MYOCARDIAL ISCHAEMIA 8 0.0007
465 SKIN HYPERPIGMENTATION 6 0.0007
466 HYPOTHERMIA 7 0.0007
467 SKIN SWELLING 6 0.0007
468 ORTHOSTATIC HYPOTENSION 12 0.0007
469 RESPIRATORY DISTRESS 19 0.0007
470 MOTOR DYSFUNCTION 7 0.0007
471 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
472 HYPERCHLORHYDRIA 4 0.0007
473 CHOLESTASIS 13 0.0007
474 LOWER LIMB FRACTURE 13 0.0007
475 MEDICAL DEVICE COMPLICATION 5 0.0007
476 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
477 JOINT RANGE OF MOTION DECREASED 9 0.0007
478 MYOSITIS 6 0.0007
479 ANAL INCONTINENCE 6 0.0007
480 STAPHYLOCOCCAL INFECTION 22 0.0007
481 HEPATITIS C 8 0.0007
482 ATRIAL FIBRILLATION 64 0.0007
483 AORTIC ANEURYSM 5 0.0007
484 HIP FRACTURE 21 0.0007
485 ABDOMINAL DISTENSION 68 0.0007
486 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
487 LACTIC ACIDOSIS 21 0.0006
488 HAEMOLYSIS 5 0.0006
489 PLATELET COUNT DECREASED 69 0.0006
490 ARTHRITIS INFECTIVE 3 0.0006
491 HYPOMAGNESAEMIA 9 0.0006
492 COORDINATION ABNORMAL 9 0.0006
493 HYPOALBUMINAEMIA 5 0.0006
494 DEVICE OCCLUSION 9 0.0006
495 GASTROINTESTINAL INFLAMMATION 5 0.0006
496 ARTERIOSCLEROSIS 6 0.0006
497 TORSADE DE POINTES 5 0.0006
498 BLOOD POTASSIUM DECREASED 19 0.0006
499 GASTRIC ULCER 12 0.0006
500 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
501 ABDOMINAL PAIN UPPER 129 0.0006
502 HYPOPHAGIA 16 0.0006
503 HYPOXIA 22 0.0006
504 BLOOD DISORDER 5 0.0006
505 NEPHROPATHY TOXIC 7 0.0006
506 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
507 STENT PLACEMENT 5 0.0006
508 RESPIRATORY ARREST 17 0.0006
509 EPISTAXIS 46 0.0006
510 HYPERTENSION 130 0.0006
511 POLYP 4 0.0006
512 ESCHERICHIA INFECTION 5 0.0006
513 MUSCLE TWITCHING 14 0.0006
514 ABASIA 15 0.0006
515 PULMONARY CONGESTION 8 0.0006
516 BONE DENSITY DECREASED 19 0.0006
517 PRODUCT FORMULATION ISSUE 4 0.0006
518 OVERDOSE 129 0.0006
519 OSTEOPENIA 9 0.0006
520 HAEMATEMESIS 15 0.0006
521 CARDIOVASCULAR DISORDER 15 0.0006
522 HAEMATURIA 20 0.0006
523 DECREASED APPETITE 135 0.0006
524 TOOTH LOSS 12 0.0006
525 PANCREATITIS ACUTE 13 0.0006
526 SEIZURE 66 0.0006
527 RENAL PAIN 6 0.0006
528 RASH ERYTHEMATOUS 27 0.0006
529 HAND FRACTURE 4 0.0006
530 OEDEMA PERIPHERAL 68 0.0006
531 RASH PRURITIC 30 0.0006
532 DERMATITIS BULLOUS 4 0.0006
533 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
534 MULTIPLE FRACTURES 9 0.0005
535 GASTROINTESTINAL PAIN 6 0.0005
536 INCREASED TENDENCY TO BRUISE 5 0.0005
537 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 26 0.0005
538 COAGULOPATHY 9 0.0005
539 CHEST PAIN 100 0.0005
540 SKIN HAEMORRHAGE 8 0.0005
541 WOUND 15 0.0005
542 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
543 ASTHENIA 200 0.0005
544 DRUG INTERACTION 84 0.0005
545 PROCEDURAL COMPLICATION 4 0.0005
546 GASTRIC HAEMORRHAGE 6 0.0005
547 DYSPNOEA 294 0.0005
548 ELECTROLYTE IMBALANCE 6 0.0005
549 BLISTER 29 0.0005
550 IMPAIRED WORK ABILITY 11 0.0005
551 CARDIAC DISORDER 48 0.0005
552 BODY TEMPERATURE DECREASED 5 0.0005
553 SINUS DISORDER 10 0.0005
554 INABILITY TO AFFORD MEDICATION 5 0.0005
555 BLOOD PRESSURE ABNORMAL 10 0.0005
556 ULCER 8 0.0005
557 UPPER LIMB FRACTURE 10 0.0005
558 SKIN DISCOLOURATION 23 0.0005
559 PRODUCT PHYSICAL ISSUE 10 0.0005
560 SEASONAL ALLERGY 7 0.0005
561 GASTRITIS 13 0.0005
562 ORAL PAIN 11 0.0005
563 BODY TEMPERATURE INCREASED 10 0.0005
564 THROMBOSIS 39 0.0005
565 PRODUCT USE ISSUE 91 0.0005
566 SPINAL COMPRESSION FRACTURE 4 0.0005
567 SKELETAL INJURY 5 0.0005
568 PANCYTOPENIA 27 0.0005
569 THROMBOCYTOPENIA 54 0.0005
570 PRODUCTIVE COUGH 23 0.0005
571 TENDERNESS 5 0.0005
572 WEIGHT FLUCTUATION 5 0.0005
573 BLOOD SODIUM DECREASED 9 0.0005
574 INFECTION 69 0.0005
575 MYOCARDIAL INFARCTION 83 0.0005
576 PRODUCT DOSE OMISSION 31 0.0005
577 SKIN LESION 13 0.0005
578 SUDDEN DEATH 5 0.0005
579 SLEEP APNOEA SYNDROME 9 0.0005
580 URINARY TRACT INFECTION 80 0.0005
581 BODY HEIGHT DECREASED 5 0.0005
582 SCAR 8 0.0005
583 HAEMOPTYSIS 13 0.0005
584 CONFUSIONAL STATE 75 0.0005
585 ANXIETY 132 0.0005
586 HIATUS HERNIA 6 0.0005
587 PYELONEPHRITIS 4 0.0005
588 MOBILITY DECREASED 33 0.0005
589 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
590 GROIN PAIN 4 0.0005
591 HYPOKALAEMIA 21 0.0005
592 MENTAL IMPAIRMENT 11 0.0005
593 IMMUNOSUPPRESSION 4 0.0005
594 PRESYNCOPE 11 0.0005
595 ANKLE FRACTURE 7 0.0005
596 FALL 150 0.0005
597 EJECTION FRACTION DECREASED 7 0.0004
598 UNEVALUABLE EVENT 34 0.0004
599 CEREBROVASCULAR ACCIDENT 76 0.0004
600 GASTROINTESTINAL INFECTION 4 0.0004
601 CYANOSIS 7 0.0004
602 CHILLS 52 0.0004
603 OCULAR HYPERAEMIA 21 0.0004
604 LIMB INJURY 12 0.0004
605 AGEUSIA 11 0.0004
606 PNEUMONIA ASPIRATION 11 0.0004
607 CHOLECYSTECTOMY 5 0.0004
608 OSTEOPOROSIS 18 0.0004
609 RASH 190 0.0004
610 ABDOMINAL PAIN LOWER 11 0.0004
611 SHOCK 10 0.0004
612 IRON DEFICIENCY ANAEMIA 4 0.0004
613 BLOOD TEST ABNORMAL 6 0.0004
614 LACERATION 4 0.0004
615 HAEMATOMA 11 0.0004
616 VENTRICULAR TACHYCARDIA 7 0.0004
617 FOOT FRACTURE 8 0.0004
618 BLOOD URINE PRESENT 8 0.0004
619 INTENTIONAL DOSE OMISSION 12 0.0004
620 BRONCHOSPASM 6 0.0004
621 DIABETES MELLITUS 32 0.0004
622 CEREBRAL HAEMORRHAGE 15 0.0004
623 ACCIDENT 5 0.0004
624 BLOOD PRESSURE INCREASED 64 0.0004
625 MUSCLE RIGIDITY 5 0.0004
626 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
627 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
628 TYPE 2 DIABETES MELLITUS 14 0.0004
629 ERUCTATION 8 0.0004
630 DEPRESSION 94 0.0004
631 DIZZINESS POSTURAL 4 0.0004
632 DYSSTASIA 12 0.0004
633 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
634 NO THERAPEUTIC RESPONSE 5 0.0004
635 DYSURIA 15 0.0004
636 THERAPY CHANGE 4 0.0004
637 PYREXIA 140 0.0004
638 GENERALISED OEDEMA 5 0.0004
639 EYE SWELLING 15 0.0004
640 TOOTH EXTRACTION 5 0.0004
641 ARRHYTHMIA 19 0.0004
642 CHEST DISCOMFORT 41 0.0004
643 GENERAL PHYSICAL HEALTH DETERIORATION 46 0.0004
644 BRADYCARDIA 21 0.0004
645 BLOOD COUNT ABNORMAL 6 0.0004
646 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
647 MALAISE 173 0.0004
648 ISCHAEMIC STROKE 7 0.0004
649 NEUTROPHIL COUNT INCREASED 4 0.0004
650 WEIGHT DECREASED 109 0.0004
651 SYNCOPE 39 0.0004
652 RIB FRACTURE 8 0.0004
653 ATRIOVENTRICULAR BLOCK 3 0.0004
654 LUNG DISORDER 19 0.0004
655 MUSCULAR WEAKNESS 44 0.0004
656 TOOTHACHE 7 0.0004
657 RESTLESS LEGS SYNDROME 7 0.0004
658 HYPERSOMNIA 11 0.0004
659 PETECHIAE 4 0.0004
660 LETHARGY 22 0.0004
661 DEHYDRATION 51 0.0004
662 DERMATITIS 8 0.0004
663 FOLLICULITIS 4 0.0004
664 JOINT STIFFNESS 10 0.0004
665 SCRATCH 4 0.0004
666 HALLUCINATION, VISUAL 8 0.0004
667 THERAPY NON-RESPONDER 17 0.0004
668 RENAL FAILURE ACUTE 16 0.0004
669 AGRANULOCYTOSIS 7 0.0004
670 BLOOD PRESSURE FLUCTUATION 9 0.0004
671 LIVER FUNCTION TEST INCREASED 8 0.0004
672 HEPATIC CIRRHOSIS 7 0.0004
673 MUSCLE TIGHTNESS 6 0.0004
674 FRACTURE 7 0.0004
675 BACK DISORDER 6 0.0004
676 LYMPHADENOPATHY 13 0.0004
677 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
678 ACUTE CORONARY SYNDROME 3 0.0004
679 PROCEDURAL PAIN 10 0.0004
680 URINARY RETENTION 12 0.0004
681 MASS 5 0.0004
682 KIDNEY INFECTION 7 0.0004
683 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
684 DIZZINESS 177 0.0004
685 SINUS TACHYCARDIA 5 0.0004
686 DERMATITIS CONTACT 4 0.0004
687 SCAB 4 0.0004
688 DYSGEUSIA 26 0.0003
689 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
690 ANAPHYLACTIC SHOCK 9 0.0003
691 PULMONARY EMBOLISM 33 0.0003
692 THERAPEUTIC RESPONSE DECREASED 21 0.0003
693 PAIN 212 0.0003
694 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
695 LOCAL SWELLING 6 0.0003
696 MUSCLE SPASMS 63 0.0003
697 FATIGUE 267 0.0003
698 SPLENOMEGALY 4 0.0003
699 BACK PAIN 79 0.0003
700 COVID-19 PNEUMONIA 4 0.0003
701 PRODUCT PRESCRIBING ERROR 8 0.0003
702 CHOLECYSTITIS 4 0.0003
703 LOSS OF CONSCIOUSNESS 43 0.0003
704 POLYNEUROPATHY 4 0.0003
705 FREQUENT BOWEL MOVEMENTS 9 0.0003
706 DRUG INTOLERANCE 32 0.0003
707 PALLOR 9 0.0003
708 HERPES ZOSTER 19 0.0003
709 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
710 HYPERGLYCAEMIA 12 0.0003
711 GAIT DISTURBANCE 63 0.0003
712 INSURANCE ISSUE 5 0.0003
713 MUSCLE SPASTICITY 4 0.0003
714 BONE PAIN 19 0.0003
715 MEDICATION ERROR 18 0.0003
716 HEART RATE INCREASED 32 0.0003
717 LUNG INFECTION 5 0.0003
718 HAIR COLOUR CHANGES 4 0.0003
719 COUGH 90 0.0003
720 HYPONATRAEMIA 18 0.0003
721 PAIN IN JAW 9 0.0003
722 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
723 BRAIN OEDEMA 4 0.0003
724 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
725 HAEMORRHAGE 33 0.0003
726 PNEUMOTHORAX 5 0.0003
727 MUSCULOSKELETAL DISORDER 6 0.0003
728 CYSTITIS 10 0.0003
729 CONTUSION 30 0.0003
730 PERIPHERAL SWELLING 48 0.0003
731 HEART RATE IRREGULAR 7 0.0003
732 RASH GENERALISED 8 0.0003
733 SWELLING FACE 20 0.0003
734 PLATELET COUNT INCREASED 4 0.0003
735 MUCOSAL INFLAMMATION 8 0.0003
736 NEUROPATHY PERIPHERAL 29 0.0003
737 IMPAIRED HEALING 10 0.0003
738 IMMUNE SYSTEM DISORDER 4 0.0003
739 DISORIENTATION 12 0.0003
740 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
741 DRUG LEVEL INCREASED 5 0.0003
742 CYTOMEGALOVIRUS INFECTION 5 0.0003
743 BALANCE DISORDER 26 0.0003
744 VIRAL INFECTION 10 0.0003
745 LEUKOPENIA 15 0.0003
746 CYTOKINE RELEASE SYNDROME 6 0.0003
747 HAIR TEXTURE ABNORMAL 4 0.0003
748 PRODUCT ADMINISTRATION ERROR 6 0.0003
749 TASTE DISORDER 6 0.0003
750 PAIN IN EXTREMITY 87 0.0003
751 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
752 EPILEPSY 9 0.0003
753 TACHYPNOEA 4 0.0003
754 GINGIVAL BLEEDING 4 0.0003
755 ACUTE HEPATIC FAILURE 4 0.0003
756 NO ADVERSE EVENT 53 0.0003
757 DYSARTHRIA 11 0.0003
758 HALLUCINATION 22 0.0003
759 CORONARY ARTERY OCCLUSION 4 0.0003
760 DIABETIC KETOACIDOSIS 7 0.0003
761 FEMUR FRACTURE 9 0.0003
762 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
763 SURGERY 17 0.0003
764 SWOLLEN TONGUE 9 0.0003
765 NEURALGIA 7 0.0003
766 FEELING COLD 8 0.0003
767 NECK PAIN 16 0.0003
768 PANCREATITIS 15 0.0003
769 BRONCHITIS 21 0.0003
770 NEPHROLITHIASIS 13 0.0003
771 THERAPY INTERRUPTED 20 0.0003
772 SUBDURAL HAEMATOMA 4 0.0003
773 HYPOACUSIS 12 0.0003
774 SKIN CANCER 6 0.0003
775 DISTURBANCE IN ATTENTION 15 0.0003
776 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
777 OFF LABEL USE 243 0.0003
778 FEELING HOT 17 0.0003
779 MYELODYSPLASTIC SYNDROME 4 0.0003
780 BACK INJURY 3 0.0003
781 HYPOKINESIA 4 0.0003
782 ACCIDENTAL OVERDOSE 10 0.0003
783 PALPITATIONS 32 0.0003
784 SOMNOLENCE 55 0.0003
785 INFLAMMATION 14 0.0003
786 EXPIRED PRODUCT ADMINISTERED 9 0.0003
787 DISEASE PROGRESSION 32 0.0003
788 CONJUNCTIVITIS 5 0.0003
789 COLITIS ULCERATIVE 12 0.0003
790 RASH PAPULAR 6 0.0003
791 ADVERSE DRUG REACTION 24 0.0003
792 OXYGEN SATURATION DECREASED 15 0.0003
793 BLOOD GLUCOSE INCREASED 50 0.0003
794 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
795 GASTRIC DISORDER 9 0.0003
796 DRUG DISPENSING ERROR 4 0.0003
797 THYROID DISORDER 4 0.0003
798 VISION BLURRED 35 0.0003
799 DRY SKIN 34 0.0003
800 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
801 THERAPY CESSATION 13 0.0003
802 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
803 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
804 COMA 12 0.0003
805 CATARACT 15 0.0003
806 PRESCRIBED UNDERDOSE 5 0.0003
807 BLOOD GLUCOSE DECREASED 12 0.0002
808 NIGHT SWEATS 8 0.0002
809 MUSCULOSKELETAL PAIN 13 0.0002
810 LIVER DISORDER 11 0.0002
811 STOMATITIS 15 0.0002
812 MYALGIA 42 0.0002
813 DYSKINESIA 10 0.0002
814 ANGINA PECTORIS 7 0.0002
815 EYE DISORDER 8 0.0002
816 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
817 BURNING SENSATION 17 0.0002
818 HEPATIC FUNCTION ABNORMAL 9 0.0002
819 VISUAL ACUITY REDUCED 8 0.0002
820 FUNGAL INFECTION 8 0.0002
821 MUSCULOSKELETAL STIFFNESS 21 0.0002
822 GAIT INABILITY 8 0.0002
823 EYE PRURITUS 8 0.0002
824 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
825 FEELING ABNORMAL 57 0.0002
826 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
827 ARTHRALGIA 98 0.0002
828 PARAESTHESIA 37 0.0002
829 SWELLING 22 0.0002
830 CIRCULATORY COLLAPSE 4 0.0002
831 DRY MOUTH 19 0.0002
832 JOINT INJURY 5 0.0002
833 RESPIRATORY DISORDER 7 0.0002
834 MUSCULOSKELETAL DISCOMFORT 4 0.0002
835 POOR QUALITY SLEEP 5 0.0002
836 DEEP VEIN THROMBOSIS 15 0.0002
837 AMNESIA 15 0.0002
838 RESPIRATORY TRACT INFECTION 6 0.0002
839 PRODUCT DISPENSING ERROR 5 0.0002
840 DISCOMFORT 14 0.0002
841 DEAFNESS 6 0.0002
842 HEART RATE DECREASED 8 0.0002
843 INTERSTITIAL LUNG DISEASE 11 0.0002
844 HYPOAESTHESIA 34 0.0002
845 URTICARIA 38 0.0002
846 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
847 FEBRILE NEUTROPENIA 15 0.0002
848 HEAD DISCOMFORT 4 0.0002
849 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
850 SKIN EXFOLIATION 19 0.0002
851 INFLUENZA 25 0.0002
852 GALLBLADDER DISORDER 4 0.0002
853 THIRST 4 0.0002
854 TREMOR 37 0.0002
855 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
856 HEAD INJURY 7 0.0002
857 NEUTROPHIL COUNT DECREASED 9 0.0002
858 NEUTROPENIA 30 0.0002
859 CONDITION AGGRAVATED 67 0.0002
860 DRUG EFFECT INCOMPLETE 8 0.0002
861 BLOOD GLUCOSE ABNORMAL 4 0.0002
862 POLLAKIURIA 9 0.0002
863 APHONIA 3 0.0002
864 TACHYCARDIA 19 0.0002
865 CHOLELITHIASIS 7 0.0002
866 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
867 PHOTOPHOBIA 4 0.0002
868 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 43 0.0002
869 COVID-19 37 0.0002
870 LIP SWELLING 7 0.0002
871 SPEECH DISORDER 11 0.0002
872 SKIN DISORDER 7 0.0002
873 PRESCRIBED OVERDOSE 4 0.0002
874 NASOPHARYNGITIS 38 0.0002
875 HEADACHE 129 0.0002
876 NASAL CONGESTION 12 0.0002
877 THROAT IRRITATION 9 0.0002
878 RASH MACULAR 7 0.0002
879 APHASIA 6 0.0002
880 SLEEP DISORDER 14 0.0002
881 VERTIGO 12 0.0002
882 BLINDNESS 8 0.0002
883 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
884 HEPATITIS 5 0.0002
885 ACUTE MYELOID LEUKAEMIA 3 0.0002
886 NERVOUS SYSTEM DISORDER 6 0.0002
887 AGITATION 14 0.0002
888 ABSCESS 3 0.0002
889 HYPERHIDROSIS 24 0.0002
890 FEAR 5 0.0002
891 JAUNDICE 5 0.0002
892 DRUG EFFECT DECREASED 10 0.0002
893 DEVICE MALFUNCTION 13 0.0002
894 HYPERSENSITIVITY 34 0.0002
895 ANGIOEDEMA 8 0.0002
896 PRODUCT DOSE OMISSION ISSUE 53 0.0002
897 TRANSAMINASES INCREASED 4 0.0002
898 TOOTH DISORDER 4 0.0002
899 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
900 DEMENTIA 5 0.0002
901 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
902 EYE PAIN 10 0.0002
903 INSOMNIA 47 0.0002
904 PRODUCT AVAILABILITY ISSUE 4 0.0002
905 HOT FLUSH 13 0.0002
906 COGNITIVE DISORDER 8 0.0002
907 URINARY INCONTINENCE 5 0.0002
908 RHABDOMYOLYSIS 7 0.0002
909 ILLNESS 17 0.0002
910 UNDERDOSE 12 0.0002
911 ALOPECIA 32 0.0002
912 OROPHARYNGEAL PAIN 15 0.0002
913 ERYTHEMA 33 0.0002
914 HYPOTHYROIDISM 5 0.0002
915 DIPLOPIA 4 0.0002
916 ECZEMA 8 0.0002
917 ARTHRITIS 12 0.0002
918 ADVERSE EVENT 14 0.0002
919 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
920 PAIN OF SKIN 4 0.0001
921 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
922 TOXICITY TO VARIOUS AGENTS 25 0.0001
923 ILL-DEFINED DISORDER 9 0.0001
924 EXTRA DOSE ADMINISTERED 6 0.0001
925 BLOOD BILIRUBIN INCREASED 4 0.0001
926 WEIGHT INCREASED 33 0.0001
927 DISEASE RECURRENCE 7 0.0001
928 MOOD ALTERED 4 0.0001
929 ABNORMAL DREAMS 4 0.0001
930 ANAPHYLACTIC REACTION 8 0.0001
931 INJURY 10 0.0001
932 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
933 PRODUCT USE IN UNAPPROVED INDICATION 35 0.0001
934 CONVULSION 8 0.0001
935 RHINORRHOEA 9 0.0001
936 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
937 DEVICE LEAKAGE 6 0.0001
938 MEMORY IMPAIRMENT 19 0.0001
939 DEVICE DISLOCATION 6 0.0001
940 DYSPHONIA 8 0.0001
941 RESTLESSNESS 5 0.0001
942 INCORRECT DOSE ADMINISTERED 31 0.0001
943 PSYCHOTIC DISORDER 4 0.0001
944 NEOPLASM MALIGNANT 9 0.0001
945 JOINT SWELLING 16 0.0001
946 LACRIMATION INCREASED 4 0.0001
947 TINNITUS 6 0.0001
948 LIMB DISCOMFORT 4 0.0001
949 DRUG-INDUCED LIVER INJURY 4 0.0001
950 ABNORMAL BEHAVIOUR 5 0.0001
951 ARTHROPATHY 7 0.0001
952 INTENTIONAL PRODUCT MISUSE 11 0.0001
953 DEVICE ISSUE 11 0.0001
954 INFLUENZA LIKE ILLNESS 10 0.0001
955 TREATMENT FAILURE 10 0.0001
956 ROAD TRAFFIC ACCIDENT 5 0.0001
957 FLUSHING 12 0.0001
958 WHEEZING 7 0.0001
959 PRODUCT QUALITY ISSUE 16 0.0001
960 HEPATIC ENZYME INCREASED 8 0.0001
961 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
962 DRUG INEFFECTIVE 153 0.0001
963 NIGHTMARE 4 0.0001
964 VAGINAL HAEMORRHAGE 5 0.0001
965 DEPRESSED MOOD 6 0.0001
966 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
967 PANIC ATTACK 4 0.0001
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
969 SKIN IRRITATION 5 0.0001
970 DRY EYE 5 0.0001
971 IRRITABILITY 6 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
973 LUNG NEOPLASM MALIGNANT 4 0.0001
974 OSTEOARTHRITIS 4 0.0001
975 MIGRAINE 9 0.0001
976 INFUSION RELATED REACTION 6 0.0001
977 VISUAL IMPAIRMENT 11 0.0001
978 ANGER 3 0.0001
979 ASTHMA 10 0.0001
980 BLOOD CHOLESTEROL INCREASED 4 0.0001
981 RENAL CANCER 4 0.0001
982 AGGRESSION 4 0.0001
983 ACNE 6 0.0001
984 SINUSITIS 8 0.0001
985 INTENTIONAL OVERDOSE 5 0.0001
986 EYE IRRITATION 4 0.0001
987 PRODUCT SUBSTITUTION ISSUE 4 0.0001
988 SUICIDAL IDEATION 6 0.0001
989 EXPOSURE DURING PREGNANCY 4 0.0001
990 DEVICE DIFFICULT TO USE 4 0.0001
991 INJECTION SITE BRUISING 4 0.0001
992 PROSTATE CANCER 4 0.0000
993 RHEUMATOID ARTHRITIS 4 0.0000
994 PSORIASIS 4 0.0000
995 INJECTION SITE PAIN 4 0.0000